Dyadic International (NASDAQ:DYAI) Stock Price Passes Above 50 Day Moving Average – Time to Sell?

Shares of Dyadic International, Inc. (NASDAQ:DYAI) passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.56 and traded as high as $1.99. Dyadic International shares last traded at $1.73, with a volume of 171,662 shares traded.

Wall Street Analyst Weigh In

Separately, HC Wainwright reiterated a “buy” rating and set a $6.00 price objective on shares of Dyadic International in a research note on Thursday, November 14th.

Dyadic International Trading Down 11.1 %

The company has a debt-to-equity ratio of 1.54, a quick ratio of 5.15 and a current ratio of 5.15. The company has a 50 day moving average of $1.56 and a two-hundred day moving average of $1.39. The stock has a market cap of $51.04 million, a PE ratio of -7.50 and a beta of 0.89.

Dyadic International (NASDAQ:DYAI) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.06. Dyadic International had a negative net margin of 188.09% and a negative return on equity of 149.16%. The firm had revenue of $1.96 million during the quarter, compared to analysts’ expectations of $1.05 million. During the same period last year, the business earned ($0.06) earnings per share. Sell-side analysts anticipate that Dyadic International, Inc. will post -0.18 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Dyadic International

A hedge fund recently raised its stake in Dyadic International stock. Chapin Davis Inc. raised its stake in Dyadic International, Inc. (NASDAQ:DYAI) by 2.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 868,301 shares of the biotechnology company’s stock after purchasing an additional 21,000 shares during the quarter. Chapin Davis Inc. owned 2.97% of Dyadic International worth $903,000 at the end of the most recent reporting period. 27.95% of the stock is owned by institutional investors.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.